Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO's 2012 Legislative Priorities - Part II

BIOtech-NOW's Tracy Cooley discusses the legislative year ahead with Brent Del Monte, BIO's Vice President of Federal Government Relations.

HIV/AIDS and Biotechnology

Learn about the role biotechnology plays in the on-going fight against HIV/AIDS.

Podcast: Stephen Rose, Ph.D., the Foundation Fighting Blindness

Diseases of the eye affect more than 10 million Americans, and biotechnology holds great promise for treatments and cures

Exhibiting at the 2012 BIO International Convention

Why should you exhibit at the 2012 BIO International Convention in Boston?

New York City Expects Big Pay Off From New Tech Campus

...

BIO's 2012 Legislative Priorities

BIOtech-NOW's Tracy Cooley discusses the legislative year ahead with Brent Del Monte, BIO's Vice President of Federal Government Relations. In this two part series, Del Monte discusses the outlook for 2012 and legislative priorities.

Podcast with Aaron Miscenich

Aaron Miscenich, president of the New Orleans BioInnovation Center and chairman of LouisianaBio, discusses the bioscience economic development initiatives.

Diabetes and Biotechnology: A Shared History…A Great Future

In three minutes, this video tells the pertinent story of how recombinant DNA technology was used to produce human — or synthetic — insulin in large amounts and how it became the first biotechnology treatment approved by the FDA.

The AquAdvantage Salmon

AquAdvantage Salmon is an Atlantic Salmon which contains a "gene construct" enabling it to grow twice as fast as other Atlantic Salmon.

Laurence Marton on Personalized Medicine

BIOtech-NOW talks to Laurence Marton, Co-Chair of the Personalized Medicine World Conference 2012, about the outlook for personalized medicine.